Houghton M (November 2009). ”The long and winding road leading to the identification of the hepatitis C virus”. Journal of Hepatology 51 (5): sid. 939–48. doi:10.1016/j.jhep.2009.08.004. PMID 19781804.
Nelson, PK; Mathers, BM, Cowie, B, Hagan, H, Des Jarlais, D, Horyniak, D, Degenhardt, L (2011-08-13). ”Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.”. Lancet 378 (9791): sid. 571–83. doi:10.1016/S0140-6736(11)61097-0. PMID 21802134.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (January 2007). ”Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach”. Digestive and Liver Disease 39 (1): sid. 2–17. doi:10.1016/j.dld.2006.06.008. PMID 16884964.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (December 2011). ”An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region”. Liver Int.. doi:10.1111/j.1478-3231.2011.02684.x. PMID 22142261.
Xia, X; Luo, J, Bai, J, Yu, R (2008 Oct). ”Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public health 122 (10): sid. 990–1003. doi:10.1016/j.puhe.2008.01.014. PMID 18486955.
Tohme RA, Holmberg SD (June 2010). ”Is sexual contact a major mode of hepatitis C virus transmission?”. Hepatology 52 (4): sid. 1497–505. doi:10.1002/hep.23808. PMID 20635398.
Lock G, Dirscherl M, Obermeier F, et al. (September 2006). ”Hepatitis C —contamination of toothbrushes: myth or reality?”. J. Viral Hepat. 13 (9): sid. 571–3. doi:10.1111/j.1365-2893.2006.00735.x. PMID 16907842.
Halliday, J; Klenerman, P, Barnes, E (2011 May). ”Vaccination for hepatitis C virus: closing in on an evasive target.”. Expert review of vaccines 10 (5): sid. 659–72. doi:10.1586/erv.11.55. PMID 21604986.
Torresi, J; Johnson, D, Wedemeyer, H (2011 Jun). ”Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.”. Journal of hepatology 54 (6): sid. 1273–85. doi:10.1016/j.jhep.2010.09.040. PMID 21236312.
Foote BS, Spooner LM, Belliveau PP (September 2011). ”Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother 45 (9): sid. 1085–93. doi:10.1345/aph.1P744. PMID 21828346.
Smith LS, Nelson M, Naik S, Woten J (May 2011). ”Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother 45 (5): sid. 639–48. doi:10.1345/aph.1P430. PMID 21558488.
Alavian SM, Tabatabaei SV (April 2010). ”Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis”. J. Viral Hepat. 17 (4): sid. 236–44. doi:10.1111/j.1365-2893.2009.01170.x. PMID 19638104.
Fung J, Lai CL, Hung I, et al. (September 2008). ”Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin”. The Journal of Infectious Diseases 198 (6): sid. 808–12. doi:10.1086/591252. PMID 18657036.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). ”Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome”. Science 244 (4902): sid. 359–62. doi:10.1126/science.2523562. PMID 2523562.
Kuo G, Choo QL, Alter HJ, et al. (April 1989). ”An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis”. Science 244 (4902): sid. 362–4. doi:10.1126/science.2496467. PMID 2496467.
El Khoury, A. C.; Klimack, W. K., Wallace, C., Razavi, H. (1 December 2011). ”Economic burden of hepatitis C-associated diseases in the United States”. Journal of Viral Hepatitis. doi:10.1111/j.1365-2893.2011.01563.x.
Ahn, J; Flamm, SL (2011 Aug). ”Hepatitis C therapy: other players in the game”. Clinics in liver disease 15 (3): sid. 641–56. doi:10.1016/j.cld.2011.05.008. PMID 21867942.
Houghton M (November 2009). ”The long and winding road leading to the identification of the hepatitis C virus”. Journal of Hepatology 51 (5): sid. 939–48. doi:10.1016/j.jhep.2009.08.004. PMID 19781804.
Nelson, PK; Mathers, BM, Cowie, B, Hagan, H, Des Jarlais, D, Horyniak, D, Degenhardt, L (2011-08-13). ”Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.”. Lancet 378 (9791): sid. 571–83. doi:10.1016/S0140-6736(11)61097-0. PMID 21802134.
Mueller, S; Millonig, G, Seitz, HK (2009-07-28). ”Alcoholic liver disease and hepatitis C: a frequently underestimated combination.”. World journal of gastroenterology : WJG 15 (28): sid. 3462–71. PMID 19630099.
Alter, MJ (2007-05-07). ”Epidemiology of hepatitis C virus infection.”. World journal of gastroenterology : WJG 13 (17): sid. 2436–41. PMID 17552026.
Ozaras, R; Tahan, V (2009 Apr). ”Acute hepatitis C: prevention and treatment.”. Expert review of anti-infective therapy 7 (3): sid. 351–61. PMID 19344247.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (January 2007). ”Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach”. Digestive and Liver Disease 39 (1): sid. 2–17. doi:10.1016/j.dld.2006.06.008. PMID 16884964.
Louie, KS; Micallef, JM, Pimenta, JM, Forssen, UM (2011 Jan). ”Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.”. Journal of viral hepatitis 18 (1): sid. 1–7. PMID 20796208.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (December 2011). ”An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region”. Liver Int.. doi:10.1111/j.1478-3231.2011.02684.x. PMID 22142261.
Pondé, RA; Mikhaĭlova, A (2011 Feb). ”Hidden hazards of HCV transmission.”. Medical microbiology and immunology 200 (1): sid. 7–11. PMID 20461405.
Xia, X; Luo, J, Bai, J, Yu, R (2008 Oct). ”Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis.”. Public health 122 (10): sid. 990–1003. doi:10.1016/j.puhe.2008.01.014. PMID 18486955.
Imperial, JC (2010 Jun). ”Chronic hepatitis C in the state prison system: insights into the problems and possible solutions.”. Expert review of gastroenterology & hepatology 4 (3): sid. 355–64. PMID 20528122.
Vescio, MF; Longo, B, Babudieri, S, Starnini, G, Carbonara, S, Rezza, G, Monarca, R (2008 Apr). ”Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.”. Journal of epidemiology and community health 62 (4): sid. 305–13. PMID 18339822.
Tohme RA, Holmberg SD (June 2010). ”Is sexual contact a major mode of hepatitis C virus transmission?”. Hepatology 52 (4): sid. 1497–505. doi:10.1002/hep.23808. PMID 20635398.
Lock G, Dirscherl M, Obermeier F, et al. (September 2006). ”Hepatitis C —contamination of toothbrushes: myth or reality?”. J. Viral Hepat. 13 (9): sid. 571–3. doi:10.1111/j.1365-2893.2006.00735.x. PMID 16907842.
Lam, NC; Gotsch, PB, Langan, RC (2010-11-15). ”Caring for pregnant women and newborns with hepatitis B or C.”. American family physician 82 (10): sid. 1225–9. PMID 21121533.
Mast EE (2004). ”Mother-to-infant hepatitis C virus transmission and breastfeeding”. Advances in Experimental Medicine and Biology 554: sid. 211–6. PMID 15384578.
Senadhi, V (2011 Jul). ”A paradigm shift in the outpatient approach to liver function tests.”. Southern medical journal 104 (7): sid. 521–5. PMID 21886053.
Halliday, J; Klenerman, P, Barnes, E (2011 May). ”Vaccination for hepatitis C virus: closing in on an evasive target.”. Expert review of vaccines 10 (5): sid. 659–72. doi:10.1586/erv.11.55. PMID 21604986.
Hagan, H; Pouget, ER, Des Jarlais, DC (2011-07-01). ”A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.”. The Journal of infectious diseases 204 (1): sid. 74–83. PMID 21628661.
Torresi, J; Johnson, D, Wedemeyer, H (2011 Jun). ”Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.”. Journal of hepatology 54 (6): sid. 1273–85. doi:10.1016/j.jhep.2010.09.040. PMID 21236312.
Ilyas, JA; Vierling, JM (2011 Aug). ”An overview of emerging therapies for the treatment of chronic hepatitis C.”. Clinics in liver disease 15 (3): sid. 515–36. PMID 21867934.
Foote BS, Spooner LM, Belliveau PP (September 2011). ”Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother 45 (9): sid. 1085–93. doi:10.1345/aph.1P744. PMID 21828346.
Smith LS, Nelson M, Naik S, Woten J (May 2011). ”Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C”. Ann Pharmacother 45 (5): sid. 639–48. doi:10.1345/aph.1P430. PMID 21558488.
Alavian SM, Tabatabaei SV (April 2010). ”Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis”. J. Viral Hepat. 17 (4): sid. 236–44. doi:10.1111/j.1365-2893.2009.01170.x. PMID 19638104.
Liu, J; Manheimer, E, Tsutani, K, Gluud, C (2003 Mar). ”Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.”. The American journal of gastroenterology 98 (3): sid. 538–44. PMID 12650784.
Rambaldi, A; Jacobs, BP, Gluud, C (2007-10-17). ”Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.”. Cochrane database of systematic reviews (Online) (4): sid. CD003620. PMID 17943794.
Fung J, Lai CL, Hung I, et al. (September 2008). ”Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin”. The Journal of Infectious Diseases 198 (6): sid. 808–12. doi:10.1086/591252. PMID 18657036.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). ”Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome”. Science 244 (4902): sid. 359–62. doi:10.1126/science.2523562. PMID 2523562.
Kuo G, Choo QL, Alter HJ, et al. (April 1989). ”An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis”. Science 244 (4902): sid. 362–4. doi:10.1126/science.2496467. PMID 2496467.
Eurosurveillance editorial, team (2011-07-28). ”World Hepatitis Day 2011.”. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 16 (30). PMID 21813077.
Wong, JB (2006). ”Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.”. PharmacoEconomics 24 (7): sid. 661–72. PMID 16802842.
Ahn, J; Flamm, SL (2011 Aug). ”Hepatitis C therapy: other players in the game”. Clinics in liver disease 15 (3): sid. 641–56. doi:10.1016/j.cld.2011.05.008. PMID 21867942.
Vermehren, J; Sarrazin, C (2011 Feb). ”New HCV therapies on the horizon.”. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 17 (2): sid. 122–34. PMID 21087349.